Monte Rosa Therapeutics Net Tangible Assets

Monte Rosa Therapeutics (GLUE) currently reports a net tangible assets of $520M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Monte Rosa Therapeutics's net tangible assets history and peer comparisons.

Monte Rosa Therapeutics's net tangible assets changed from $0 to $520M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Monte Rosa Therapeutics reported $520M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $520M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Monte Rosa Therapeutics, and consider following GLUE for alerts when major investors trade the stock.

Monte Rosa Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $520M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GLUE with unrelated industries.